TY  - GEN
AU  - Berger,Anne Katrin
AU  - von Gall,Carl
AU  - Abel,Ulrich
AU  - Delorme,Stefan
AU  - Kloor,Matthias
AU  - Ose,Jennifer
AU  - Weber,Tim Frederik
AU  - Stange,Annika
AU  - Haag,Georg Martin
AU  - Haberkorn,Uwe
AU  - Lordick,Florian
AU  - Jäger,Dirk
TI  - A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
SN  - 1471-2407
PY  - 2012///0827
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - diagnostic imaging
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Fluorodeoxyglucose F18
KW  - pharmacokinetics
KW  - Humans
KW  - Male
KW  - Positron-Emission Tomography
KW  - Predictive Value of Tests
KW  - Prospective Studies
KW  - Radiopharmaceuticals
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1471-2407-12-108
ER  -